https://m2.mtmt.hu/ hun 2026-10-24 18:48 JournalArticle 32151362 ADMIN_APPROVED true Centre of Radiotherapy, National Institute of Oncology, Rath Gyorgy u. 7-9, Budapest, H-1122, Hungary Department of Oncology, Semmelweis University, Budapest, Hungary Institute of Nuclear Techniques, Budapest University of Technology and Economy, Budapest, Hungary Export Date: 12 May 2023 CODEN: RONCE Correspondence Address: Jorgo, K.; Centre of Radiotherapy, Rath Gyorgy u. 7-9, Hungary; email: jorgokliton@gmail.com Correspondence Address: Jorgo, K.; Department of Oncology, Hungary; email: jorgokliton@gmail.com Tradenames: CyberKnife M6 0 false 2026-10-21T15:13:09.789+0000 2022-03-07T10:23:07.399+0000 2021-08-21T10:28:08.555+0000 true 10062250 Molnár-Taga Márta /api/admin/10062250 Admin Molnár-Taga Márta (SE 4-es admin) true 10062250 2024-09-03T12:20:21.283+0000 2022-03-07T10:23:07.418+0000 true 10046107 Szabó Vera /api/admin/10046107 Admin Szabó Vera (BME TTK NTI admin 5) true 10046107 Admin 10067876 /api/admin/10067876 Ladányi Gusztáv (MTMT API user, admin) Ladányi Gusztáv true true Admin 10080105 /api/admin/10080105 Kériné Tornyi Katalin (MTMT ellenőrzés admin5) Kériné Tornyi Katalin true true 2024-10-17T16:16:12.275+0000 true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Jorgo, K. true true /api/journal/10013541 REVIEWED RADIOLOGY AND ONCOLOGY 1318-2099 1581-3207 true false 10013541 false 10013541 true 1318-2099 1581-3207 Journal FOREIGN 55 4 474 481 474 8 2021 The aim of the study was to evaluate acute side effects after extremely hypofractionated intensity-modulated radiotherapy (IMRT) with stereotactic body radiation therapy (SBRT) for definitive treatment of prostate cancer patients. Between February 2018 and August 2019, 205 low-, intermediate- A nd high-risk prostate cancer patients were treated with SBRT using "CyberKnife M6"linear accelerator. In low-risk patients 7.5-8 Gy was delivered to the prostate gland by each fraction. For intermediate- A nd high-risk disease a dose of 7.5-8 Gy was delivered to the prostate and 6-6.5 Gy to the seminal vesicles by each fraction with a simultaneous integrated boost (SIB) technique. A total of 5 fractions (total dose 37.5-40 Gy) were given on every second working day. Acute radiotherapy-related genitourinary (GU) and gastrointestinal (GI) side effects were assessed using Radiation Therapy Oncology Group (RTOG) scoring system. Of the 205 patients (28 low-, 115 intermediate-, 62 high-risk) treated with SBRT, 203 (99%) completed the radiotherapy as planned. The duration of radiation therapy was 1 week and 3 days. The frequencies of acute radiotherapy-related side effects were as follows: GU grade 0-17.1%, grade I-30.7%, grade II-50.7%, grade III-1.5%; and GI grade 0-62.4%, grade I-31.7%, grade II-5.9%, grade III-0%. None of the patients developed grade ≥ 4 acute toxicity. SBRT with a total dose of 37.5-40 Gy in 5 fractions appears to be a safe and well tolerated treatment option in patients with prostate cancer, associated with slight or moderate early side effects. Longer follow-up is needed to evaluate long-term toxicity and biochemical control. © 2021 true true 2021 true true true false true false GOLD 2026-10-21 true https://doi.org/10.2478/raon-2021-0031 6 0 6 5 1 6 6 5 6 6 6 5 5 5 1 0 6 5 6 5 0 2 2 Folyóiratcikk Journal Article 24 6 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2024 0 3 3 3 3 2025 0 2 2 2 2 2026 0 1 0 1 0 Q2 false false false false 2021-11-19T11:30:30.442+0000 Nukleáris Technikai Intézet (BME / TTK); Onkológiai Tanszék (SE / AOK / K); Országos Onkológiai Intézet 6 12 3 6 0 true 10080105 10067876 Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 97134361 /api/authorship/97134361 Jorgo, K. ✉ [Jorgo, Kliton (Onkológia), szerző] Országos Onkológiai Intézet; Onkológiai Tanszék (SE / AOK / K) 1 0.167 true false true Author 10064469 /api/author/10064469 Jorgo Kliton (Onkológia) Jorgo Kliton true 10064469 true Jorgo K. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 97134362 /api/authorship/97134362 Polgar, C. [Polgár, Csaba (Sugárterápia, kli...), szerző] Országos Onkológiai Intézet; Onkológiai Tanszék (SE / AOK / K) 2 0.167 false false false Author 10013383 /api/author/10013383 Polgár Csaba (Sugárterápia, klinikai onkológia) Polgár Csaba true 10013383 true Polgar C. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 97134363 /api/authorship/97134363 Stelczer, G. [Stelczer, Gábor (Orvosfizika), szerző] Országos Onkológiai Intézet; Nukleáris Technikai Intézet (BME / TTK) 3 0.167 false false false Author 10042823 /api/author/10042823 Stelczer Gábor (Orvosfizika) Stelczer Gábor true 10042823 true Stelczer G. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 97134364 /api/authorship/97134364 Major, T. [Major, Tibor (klinikai sugárfizika), szerző] Országos Onkológiai Intézet; Onkológiai Tanszék (SE / AOK / K) 4 0.167 false false false Author 10044386 /api/author/10044386 Major Tibor (klinikai sugárfizika) Major Tibor true 10044386 true Major T. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 97134365 /api/authorship/97134365 Gesztesi, L. [Gesztesi, László (Sugárterápia), szerző] Országos Onkológiai Intézet 5 0.167 false false false Author 10058289 /api/author/10058289 Gesztesi László (Sugárterápia) Gesztesi László true 10058289 true Gesztesi L. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 97134366 /api/authorship/97134366 Agoston, P. [Ágoston, Péter Zoltán (Sugárterápia, onk...), szerző] Országos Onkológiai Intézet; Onkológiai Tanszék (SE / AOK / K) 6 0.167 false true false Author 10030572 /api/author/10030572 Ágoston Péter Zoltán (Sugárterápia, onkológia) Ágoston Péter Zoltán true 10030572 true Agoston P. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 19145793 /api/publicationidentifier/19145793 DOI: 10.2478/raon-2021-0031 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true GOLD true IDENTICAL 10.2478/raon-2021-0031 https://doi.org/10.2478/raon-2021-0031 false true PublicationIdentifier 20321169 /api/publicationidentifier/20321169 WoS: 000728112000011 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 000728112000011 https://www.webofscience.com/wos/woscc/full-record/000728112000011 true true PublicationIdentifier 19145792 /api/publicationidentifier/19145792 Scopus: 85111726047 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85111726047 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85111726047 false true PublicationIdentifier 19145794 /api/publicationidentifier/19145794 PubMed: 34253001 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 34253001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=34253001&dopt=Abstract false true Keyword 1030129 /api/keyword/1030129 Prostate cancer true 1030129 true Keyword 1464008 /api/keyword/1464008 Cyberknife true 1464008 true Keyword 1616415 /api/keyword/1616415 Stereotactic radiotherapy true true Keyword 2336032 /api/keyword/2336032 extreme hypofractionation true true SjrRating 11234846 /api/sjrrating/11234846 sjr:Q2 (2021) Scopus - Radiology, Nuclear Medicine and Imaging RADIOLOGY AND ONCOLOGY 1318-2099 1581-3207 128 0.49 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 2741 /api/classificationexternal/2741 Scopus - Radiology, Nuclear Medicine and Imaging true 2741 true Q2 DIRECT true true Reference 22310035 /api/reference/22310035 1. Gurka, M.K., Chen, L.N., Bhagat, A., Moures, R., Kim, S.J., Yung, T., Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer (2015) Radiat Oncol, 10, p. 44 1 false true Reference 22310034 /api/reference/22310034 2. Katz, A.J., Kang, J., Quality of life and toxicity after SBRT for organ-confined prostate cancer, a 7-year study (2014) Front Oncol, 4, p. 301 2 false true Reference 22310033 /api/reference/22310033 3. Bolzicco, G., Favretto, M.S., Satariano, N., Scremin, E., Tambone, C., Tasca, A., A single-center study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapy (2013) BMC Urol, 13, p. 49 3 false true Reference 22310032 /api/reference/22310032 4. Wang, K., Chen, R.C., Kane, B., Medbery, C., Underhill, K., Gray, J., Patient and dosimetric predictors of genitourinary and bowel quality of life after prostate SBRT: Secondary analysis of a multi-institutional trial (2018) Int J Radiat Oncol Biol Phys, 102, pp. 1430-1437 4 false true Reference 22310031 /api/reference/22310031 5. Murthy, V., Sinha, S., Kannan, S., Datta, D., Das, R., Bakshi, G., Safety of prostate stereotactic body radiation therapy after Transurethral Resection of Prostate (TURP): A propensity score matched pair analysis (2019) Pract Radiat Oncol, 5, pp. 347-353 5 false true Reference 22310030 /api/reference/22310030 6. Hannan, R., Tumati, V., Xie, X.J., Cho, L.C., Kavanagh, B., Brindle, J., Stereotactic body radiation therapy for low and intermediate risk prostate cancer-Results from a multi-institutional clinical trial (2016) Eur J Cancer, 59, pp. 142-151 6 false true Reference 22310029 /api/reference/22310029 7. Anwar, M., Weinberg, V., Seymour, Z., Hsu, J., Roach, M., Gottschalk, A., Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer (2016) Radiat Oncol, 11, p. 8. , 3rd 7 false true Reference 22310028 /api/reference/22310028 8. Chen, L.N., Suy, S., Wang, H., Bhagat, A., Woo, J., Moures, R., Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer (2014) Radiat Oncol, 9, p. 148 8 false true Reference 22310027 /api/reference/22310027 9. Mantz, C., A Phase II trial of stereotactic ablative body radiotherapy for low-risk prostate cancer using a non-robotic linear accelerator and realtime target tracking: Report of toxicity, quality of life, and disease control outcomes with 5-year minimum follow-up (2014) Front Oncol, 4, p. 279 9 false true Reference 22310026 /api/reference/22310026 10. Oliai, C., Lanciano, R., Sprandio, B., Yang, J., Lamond, J., Arrigo, S., Stereotactic body radiation therapy for the primary treatment of localized prostate cancer (2013) J Radiat Oncol, 2, pp. 63-70 10 false true Reference 22310025 /api/reference/22310025 11. Bolzicco, G., Favretto, M.S., Satariano, N., Scremin, E., Tambone, C., Tasca, A., A single-center study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapy (2013) BMC Urol, 13, p. 49 11 false true Reference 22310024 /api/reference/22310024 12. McBride, S.M., Wong, D.S., Dombrowski, J.J., Harkins, B., Tapella, P., Hanscom, H., Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma: Preliminary results of a multi-institutional phase 1 feasibility trial (2012) Cancer, 118, pp. 3681-3690 12 false true Reference 22310023 /api/reference/22310023 13. Jabbari, S., Weinberg, V.K., Kaprealian, T., Hsu, I., Ma, L., Chuang, C., Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: Technique, early toxicity, and PSA response (2012) Int J Radiat Oncol Biol Phys, 82, pp. 228-234 13 false true Reference 22310022 /api/reference/22310022 14. Freeman, D.E., King, C.R., Stereotactic body radiotherapy for low-risk prostate cancer: Five-year outcomes (2011) Radiat Oncol, 6, p. 3 14 false true Reference 22310021 /api/reference/22310021 15. Boike, T.P., Lotan, Y., Cho, L.C., Brindle, J., Derose, P., Xie, X., Phase I dose-escalation study of stereotactic body radiation therapy for low- A nd intermediate-risk prostate cancer (2011) J Clin Oncol, 29, pp. 2020-2026 15 false true Reference 22310020 /api/reference/22310020 16. Katz, A.J., Santoro, M., Ashley, R., Diblasio, F., Witten, M., Stereotactic body radiotherapy for organ-confined prostate cancer (2010) BMC Urol, 10, p. 1 16 false true Reference 22310019 /api/reference/22310019 17. Madsen, B.L., Hsi, R.A., Pham, H.T., Fowler, J., Esagui, L., Corman, J., Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5Gy in five fractions for localized disease: First clinical trial results (2007) Int J Radiat Oncol Biol Phys, 67, pp. 1099-1105 17 false true Reference 22310018 /api/reference/22310018 18. Widmark, A., Gunnlaugsson, A., Beckman, L., Thellenberg-Karlsson, C., Hoyer, M., Lagerlund, M., Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial (2019) Lancet, 394, pp. 385-395 18 false true Reference 22310017 /api/reference/22310017 19. Brand, D.H., Tree, A.C., Ostler, P., Van Der, V.H., Loblaw, A., Chu, W., Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): Acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial (2019) Lancet Oncol, 20, pp. 1531-1543 19 false true Reference 22310016 /api/reference/22310016 20. Hodges, J.C., Lotan, Y., Boike, T.P., Benton, R., Barrier, A., Timmerman, R., Cost-effectiveness analysis of SBRT versus IMRT: An emerging initial radiation treatment option for organ-confined prostate cancer (2012) Am J Manag Care, 18, pp. e186-e193 20 false true Reference 22310015 /api/reference/22310015 21. Dandapani, S.V., Sanda, M.G., Measuring health-related quality of life consequences from primary treatment for early-stage prostate cancer (2008) Semin Radiat Oncol, 18, pp. 67-72 21 false true Reference 22310014 /api/reference/22310014 22. Holmboe, E.S., Concato, J., Treatment decisions for localized prostate cancer: Asking men what's important (2000) J Gen Intern Med, 15, pp. 694-701 22 false true Reference 22310013 /api/reference/22310013 23. Cox, J.D., Stetz, J., Pajak, T.F., Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) (1995) Int J Radiat Oncol Biol Phys, 30, pp. 1341-1346 23 false true Reference 22310012 /api/reference/22310012 24. D'Amico, A.V., Moul, J., Carroll, P.R., Sun, L., Lubeck, D., Chen, M., Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era (2003) J Clin Oncol, 21, pp. 2163-2172 24 false true Reference 22310011 /api/reference/22310011 25. Jorgo, K., Agoston, P., Major, T., Takácsi-Nagy, Z., Polgár, C., Transperineal gold marker implantation for image-guided external beam radiotherapy of prostate cancer. A single institution, prospective study (2017) Strahlenther Onkol, 193, pp. 452-458 25 false true Reference 22310010 /api/reference/22310010 26. Jorgo, K., Ágoston, P., Szabó, Z., Major, T., Polgár, C., [Use of gold radionuclide markers implanted into the prostate for image-guided radiotherapy in prostate cancer: Side effects caused by the marker implantation]. [Hungarian] (2014) Magy Onkol, 58, pp. 182-187 26 false true Reference 22310009 /api/reference/22310009 27. King, C.R., Brooks, J.D., Gill, H., Presti, J.J., Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer (2012) Int J Radiat Oncol Biol Phys, 82, pp. 877-882 27 false true Reference 22310008 /api/reference/22310008 28. Loblaw, A., Cheung, P., D'Alimonte, L., Deabreu, A., Mamedov, A., Zhang, L., Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: Toxicity, biochemical, and pathological outcomes (2013) Radiother Oncol J Eur Soc Ther Radiol Oncol, 107, pp. 153-158 28 false true Reference 22310007 /api/reference/22310007 29. Aluwini, S., Van, P.R., Hoogeman, M., Kirkels, W., Kolkman-Deurloo, I., Bangma, C., Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- A nd intermediate-risk prostate cancer: Early results (2013) Radiat Oncol Lond Engl, 8, p. 84 29 false true Reference 22310006 /api/reference/22310006 30. Lee, W.R., Dignam, J.J., Amin, M.B., Bruner, D., Low, D., Swanson, G., Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer (2016) J Clin Oncol, 34, pp. 2325-2332 30 false true Reference 22310005 /api/reference/22310005 31. Catton, C.N., Lukka, H., Gu, C.S., Martin, J., Supiot, S., Chung, P., Randomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer (2017) J Clin Oncol, 35, pp. 1884-1890 31 false true Reference 22310004 /api/reference/22310004 32. Dearnaley, D., Syndikus, I., Mossop, H., Bidmead, M., Bloomfield, D., Clark, C., Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial (2016) Lancet Oncol, 17, pp. 1047-1060 32 false true Reference 22310003 /api/reference/22310003 33. Zaorsky, N.G., Studenski, M.T., Dicker, A.P., Gomella, L., Den, R., Stereotactic body radiation therapy for prostate cancer: Is the technology ready to be the standard of care? (2013) Cancer Treat Rev, 39, pp. 212-218 33 false true Reference 22310002 /api/reference/22310002 34. Arcangeli, S., Greco, C., Hypofractionated radiotherapy for organ-confined prostate cancer: Is less more? (2016) Nat Rev Urol, 13, pp. 400-408 34 false true Reference 22310001 /api/reference/22310001 35. Brenner, D.J., Hall, E.J., Fractionation and protraction for radiotherapy of prostate carcinoma (1999) Int J Radiat Oncol Biol Phys, 43, pp. 1095-1101 35 false true Reference 22310000 /api/reference/22310000 36. Hamdy, F.C., Donovan, J.L., Lane, J.A., 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer (2016) N Engl J Med, 375, pp. 1415-1424 36 false true Reference 22309999 /api/reference/22309999 37. Donovan, J.L., Hamdy, F.C., Lane, J.A., Mason, M., Metcalfe, C., Walsh, E., Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer (2016) N Engl J Med, 375, pp. 1425-1437 37 false true Reference 22309998 /api/reference/22309998 38. Heidenreich, A., Bastian, P.J., Bellmunt, J., Bolla, M., Joniau, S., Van Der, K.T., EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and local treatment with curative intent-update 2013 (2014) Eur Urol, 65, pp. 124-137 38 false true Reference 22309997 /api/reference/22309997 39. Torre, L.A., Siegel, R.L., Ward, E.M., Jemal, A., Global cancer incidence and mortality rates and trends- A n update (2016) Cancer Epidemiol Biomarkers Prev, 25, pp. 16-27 39 false true Reference 22309996 /api/reference/22309996 40. Attard, G., Parker, C., Eeles, R., Schröder, F., Tomlins, S., Tannock, I., Prostate cancer (2016) Lancet, 387, pp. 70-82 40 false true Reference 22309995 /api/reference/22309995 41. Ferlay, J., Colombet, M., Soerjomataram, I., Dyba, T., Randi, G., Bettio, M., Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018 (2018) Eur J Cancer, 103, pp. 356-387 41 false true Reference 22309994 /api/reference/22309994 42. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A., Jemal, A.G.C.S., GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, 2018 (2018) Cancer J Clin, 68, pp. 394-424 42 false true /api/publication/32151362 Jorgo K. et al. Acute side effects after definitive stereotactic body radiation therapy (SBRT) for patients with clinically localized or locally advanced prostate cancer: A single institution prospective study. (2021) RADIOLOGY AND ONCOLOGY 1318-2099 1581-3207 55 4 474-481<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10064469"><a href="/gui2/?type=authors&mode=browse&sel=10064469" target="_blank">Jorgo K. ✉ (<span class="authorship-author-name">Jorgo Kliton</span> <span class="authorAux-mtmt"> Onkológia</span>) </a> </span> <span class="author-affil">Országos Onkológiai Intézet; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Onkológiai Tanszék</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10013383"><a href="/gui2/?type=authors&mode=browse&sel=10013383" target="_blank">Polgar C. (<span class="authorship-author-name">Polgár Csaba</span> <span class="authorAux-mtmt"> Sugárterápia, klinikai onkológia</span>) </a> </span> <span class="author-affil">Országos Onkológiai Intézet; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Onkológiai Tanszék</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10042823"><a href="/gui2/?type=authors&mode=browse&sel=10042823" target="_blank">Stelczer G. (<span class="authorship-author-name">Stelczer Gábor</span> <span class="authorAux-mtmt"> Orvosfizika</span>) </a> </span> <span class="author-affil">Országos Onkológiai Intézet; <span title="Budapesti Műszaki és Gazdaságtudományi Egyetem">BME</span>/<span title="Természettudományi Kar">TTK</span>/Nukleáris Technikai Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10044386"><a href="/gui2/?type=authors&mode=browse&sel=10044386" target="_blank">Major T. (<span class="authorship-author-name">Major Tibor</span> <span class="authorAux-mtmt"> klinikai sugárfizika</span>) </a> </span> <span class="author-affil">Országos Onkológiai Intézet; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Onkológiai Tanszék</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10058289"><a href="/gui2/?type=authors&mode=browse&sel=10058289" target="_blank">Gesztesi L. (<span class="authorship-author-name">Gesztesi László</span> <span class="authorAux-mtmt"> Sugárterápia</span>) </a> </span> <span class="author-affil">Országos Onkológiai Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10030572"><a href="/gui2/?type=authors&mode=browse&sel=10030572" target="_blank">Agoston P. (<span class="authorship-author-name">Ágoston Péter Zoltán</span> <span class="authorAux-mtmt"> Sugárterápia, onkológia</span>) </a> </span> <span class="author-affil">Országos Onkológiai Intézet; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Onkológiai Tanszék</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;32151362" target="_blank">Acute side effects after definitive stereotactic body radiation therapy (SBRT) for patients with clinically localized or locally advanced prostate cancer: A single institution prospective study</a></div> <div> <span class="journal-title">RADIOLOGY AND ONCOLOGY</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1318-2099">1318-2099</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1581-3207">1581-3207</a>)</span>: <span class="journal-volume">55</span> <span class="journal-issue">4</span> <span class="page"> pp 474-481 </span> <span class="year">(2021)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_GOLD" title=" Gold "> <a style="color:blue" title="10.2478/raon-2021-0031" target="_blank" href="https://doi.org/10.2478/raon-2021-0031"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="000728112000011" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000728112000011"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85111726047" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85111726047"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="34253001" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=34253001&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Radiology, Nuclear Medicine and Imaging&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q2</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Oncology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q3</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 6</span> | Független: 5 | Függő: 1 | Nem jelölt: 0 | WoS jelölt: 5 | Scopus jelölt:&nbsp;6 | WoS/Scopus jelölt:&nbsp;6 | DOI jelölt:&nbsp;6 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;32151362&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 2 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 32151362</span> | <span class="status-data status-ADMIN_APPROVED"> Admin láttamozott </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">Scopus</span> </div> <div class="lastModified">Utolsó módosítás: 2022.03.07. 11:23 Szabó Vera (BME TTK NTI admin 5) </div> <div class="lockedBy">Központi kezelésű 2024.10.17. 18:16 Ladányi Gusztáv (MTMT API user, admin) Kériné Tornyi Katalin (MTMT ellenőrzés admin5) </div> <pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Megjegyzés</u>: Centre of Radiotherapy, National Institute of Oncology, Rath Gyorgy u. 7-9, Budapest, H-1122, Hungary Department of Oncology, Semmelweis University, Budapest, Hungary Institute of Nuclear Techniques, Budapest University of Technology and Economy, Budapest, Hungary Export Date: 12 May 2023 CODEN: RONC...</pre> </div></div>